Contact Us
Antimicrobial Resistance Diagnostics Global Market Report 2025
Global Antimicrobial Resistance Diagnostics Market Report 2025
Item added to cart!

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Antimicrobial Resistance Diagnostics Global Market Report 2025

By Product Type (Kits And Reagents, Instruments And Consumables), By Pathogen (Drug-Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRntS), Other Pathogens), By Technology (Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), Mass Spectrometry, Rapid And Point Of Care, Other Technologies), By End-User (Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Antimicrobial Resistance Diagnostics Market Overview

• Antimicrobial Resistance Diagnostics market size has reached to $4.10 billion in 2024

• Expected to grow to $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%

• Growth Driver: Rising Drug-Resistant Infections Driving The Growth Of The Market Due To The Need For Early Detection And Targeted Treatment

• Market Trend: Technological Innovations Of Multiplex PCR Assays To Enhance Diagnostic Speed And Accuracy

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Antimicrobial Resistance Diagnostics Market?

Antimicrobial resistance (AMR) diagnostics are tests used to detect the presence of microorganisms that have developed resistance to antibiotics or other antimicrobial agents. These diagnostics help identify the specific pathogen and determine which drugs it is resistant or susceptible to, enabling targeted and effective treatment. Antimicrobial resistance (AMR) diagnostics are essential for controlling the spread of resistant infections and guiding appropriate antimicrobial use in both clinical and public health settings.

The main product types in the antimicrobial resistance diagnostics market include kits and reagents, instruments, and consumables. Kits and reagents are standardized sets of chemicals and biological materials used to detect or measure specific pathogens or substances in diagnostic tests. These diagnostics are used to detect various pathogens such as drug-resistant Streptococcus pneumoniae (DRSP), drug-resistant Campylobacter (DRC), Clostridium difficile (CD), methicillin-resistant Staphylococcus aureus (MRSA), drug-resistant Neisseria gonorrhoeae (DRNG), drug-resistant Salmonella (DRNTS), and other resistant pathogens. A range of technologies is employed, including microbiology culture, immunoassay, polymerase chain reaction (PCR), next-generation sequencing (NGS), mass spectrometry, rapid and point-of-care testing, and others. The key end-users are hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, and others.

Antimicrobial Resistance Diagnostics Market Size and growth rate 2025 to 2029: Graph

What Is The Antimicrobial Resistance Diagnostics Market Size 2025 And Growth Rate?

The antimicrobial resistance diagnostics market size has grown strongly in recent years. It will grow from $4.10 billion in 2024 to $4.41 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing incidence of hospital-acquired infections, rising misuse of antibiotics in humans and animals, growing burden of multidrug-resistant organisms, increasing public health surveillance programs, and rising diagnostic testing in infectious diseases.

What Is The Antimicrobial Resistance Diagnostics Market Growth Forecast?

The antimicrobial resistance diagnostics market size is expected to see strong growth in the next few years. It will grow to $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growing demand for rapid diagnostic tools, increasing awareness of antimicrobial stewardship, rising government funding for resistance tracking, expanding use of point-of-care testing, and increasing need for early infection detection. Major trends in the forecast period include technological advancements in diagnostic platforms, innovation in resistance gene detection methods, rising investment in research and development, development of portable testing devices, and innovation in multiplex and high-throughput testing.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Antimicrobial Resistance Diagnostics Market Segmented?

1) By Product Type: Kits And Reagents, Instruments And Consumables

2) By Pathogen: Drug-Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRntS), Other Pathogens

3) By Technology: Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), Mass Spectrometry, Rapid And Point Of Care, Other Technologies

4) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Polymerase Chain Reaction (PCR) Reagents, Immunoassay Reagents, Stains And Dyes, Culture Media

2) By Instruments And Consumables: Polymerase Chain Reaction (PCR) Machines, Ultraviolet-Visible (UV-Vis) Spectrophotometers, Next-Generation Sequencing (NGS) Systems, Microarray Scanners, Automated Liquid Handlers, Sample Collection Tubes And Swabs

What Is Driving The Antimicrobial Resistance Diagnostics Market? Rising Drug-Resistant Infections Driving The Growth Of The Market Due To The Need For Early Detection And Targeted Treatment

The rising prevalence of drug-resistant infections is expected to propel the growth of the antimicrobial resistance diagnostics market going forward. Drug-resistant infections occur when bacteria, viruses, fungi, or parasites evolve mechanisms to survive exposure to medications that were previously effective against them, making standard treatments ineffective and infections harder to control. The growing prevalence of drug-resistant infections is due to the overuse of antibiotics in agriculture, where low-dose antimicrobials are routinely added to animal feed, promoting resistance that can spread to humans through the food chain. Antimicrobial resistance diagnostics, such as rapid genetic assays and culture-based sensitivity tests, play a pivotal role in combating the growing prevalence of drug-resistant infections by enabling early identification of resistant pathogens, guiding targeted therapies, and reducing the misuse of broad-spectrum antibiotics. For instance, in November 2023, according to a report published by the UK Health Security Agency (UKHSA), a government agency, the total number of antibiotic-resistant infections in England rose from 55,792 cases in 2021 to approximately 58,224 in 2022, reflecting a 4% year-on-year increase in antimicrobial resistance nationwide. Therefore, the rising prevalence of drug-resistant infections is driving the growth of the antimicrobial resistance diagnostics industry.

Who Are The Major Players In The Global Antimicrobial Resistance Diagnostics Market?

Major companies operating in the antimicrobial resistance diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMérieux S.A., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Seegene Inc., Alifax S.r.l., Accelerate Diagnostics Inc., Lumos Diagnostics Holdings Pty Ltd, Molsid SAS, Genetic

Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc., OpGen Inc., T2 Biosystems, Jiangsu Medomics Medical Technology Co. Ltd.

What Are The Key Trends Of The Global Antimicrobial Resistance Diagnostics Market? Technological Innovations Of Multiplex PCR Assays To Enhance Diagnostic Speed And Accuracy

Major companies operating in the antimicrobial resistance diagnostics market are focusing on developing innovative products such as multiplex polymerase chain reaction (PCR) assays that simultaneously detect multiple pathogens and resistance genes to enhance diagnostic efficiency and accuracy. Multiplex PCR combines numerous sets of primers in a single reaction to identify different DNA targets at once, significantly reducing time and resources. For instance, in May 2022, Vela Diagnostics, a Singapore-based molecular diagnostics company, launched the PathoKey MP urinary tract infections (UTI) ID and antimicrobial resistance (AMR) PCR Test. The product enables simultaneous detection of 14 urinary tract infection pathogens and 14 antimicrobial resistance genes, provides both automated and manual workflows, and delivers results in as little as four hours to support rapid, lab-scale AMR profiling. PathoKey MP UTI ID & AMR PCR Test is designed to empower clinical labs with faster, high-throughput detection capabilities to guide early intervention and effective antibiotic therapy.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Antimicrobial Resistance Diagnostics Market? biomérieux Acquired Specific Diagnostics To Advance Rapid Ast Technologies

In May 2022, bioMérieux S.A., a France-based biotechnology company, acquired the remaining shares in Specific Diagnostics, LLC, for $380 million (€360 million). Through this acquisition, bioMérieux deepens its commitment to accelerating rapid antimicrobial susceptibility testing by integrating Specific Diagnostics’ patented REVEAL Rapid antimicrobial susceptibility testing (AST) system, which delivers phenotypic AST (antimicrobial susceptibility testing) results directly from positive blood cultures in an average of five hours. Specific Diagnostics, LLC is a US-based firm that specializes in rapid, metabolomic signature-based antimicrobial susceptibility testing systems designed for phenotypic analysis directly from blood culture samples.

What Is The Regional Outlook For The Global Antimicrobial Resistance Diagnostics Market?

North America was the largest region in the acute care telemedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Telemedicine Market?

The acute care telemedicine market includes revenues earned by entities by providing services like virtual emergency care, remote intensive care unit monitoring, tele-stroke evaluations, virtual hospitalist support, and real-time specialist consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Antimicrobial Resistance Diagnostics Industry?

The antimicrobial resistance diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including the antimicrobial resistance diagnostics industry global market size, regional shares, competitors with the market share, detailed market segments, market trends, and opportunities, and any further data you may need to thrive in the antimicrobial resistance diagnostics industry. This antimicrobial resistance diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Antimicrobial Resistance Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.41 billion
Revenue Forecast In 2034 $5.82 billion
Growth Rate CAGR of 7.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Product Type, Pathogen, Technology, End-User, Kits And Reagents, Instruments And Consumables
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMérieux S.A., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Seegene Inc., Alifax S.r.l., Accelerate Diagnostics Inc., Lumos Diagnostics Holdings Pty Ltd, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc., OpGen Inc., T2 Biosystems, Jiangsu Medomics Medical Technology Co. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Antimicrobial Resistance Diagnostics Market Characteristics

3. Antimicrobial Resistance Diagnostics Market Trends And Strategies

4. Antimicrobial Resistance Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Antimicrobial Resistance Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Antimicrobial Resistance Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Antimicrobial Resistance Diagnostics Market Growth Rate Analysis

5.4. Global Antimicrobial Resistance Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Antimicrobial Resistance Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Antimicrobial Resistance Diagnostics Total Addressable Market (TAM)

6. Antimicrobial Resistance Diagnostics Market Segmentation

6.1. Global Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Kits And Reagents

Instruments And Consumables

6.2. Global Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drug-Resistant Streptococcus Pneumoniae (DRSP)

Drug Resistant Campylobacter (DRC)

Clostridium Difficile (CD)

Methicillin Resistant Staphylococcus Aureus (MRSA)

Drug Resistant Neisseria Gonorrhoeae (DRNG)

Drug Resistant Salmonella (DRntS)

Other Pathogens

6.3. Global Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Microbiology Culture

Immunoassay

PCR (Polymerase Chain Reaction)

NGS (Next-Generation Sequencing)

Mass Spectrometry

Rapid And Point Of Care

Other Technologies

6.4. Global Antimicrobial Resistance Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Diagnostics Laboratories

Research Institutes

Pharmaceutical And Biotechnology Companies

Other End Users

6.5. Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Deoxyribonucleic Acid (DNA) Extraction Kits

Ribonucleic Acid (RNA) Extraction Kits

Polymerase Chain Reaction (PCR) Reagents

Immunoassay Reagents

Stains And Dyes

Culture Media

6.6. Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Instruments And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polymerase Chain Reaction (PCR) Machines

Ultraviolet-Visible (UV-Vis) Spectrophotometers

Next-Generation Sequencing (NGS) Systems

Microarray Scanners

Automated Liquid Handlers

Sample Collection Tubes And Swabs

7. Antimicrobial Resistance Diagnostics Market Regional And Country Analysis

7.1. Global Antimicrobial Resistance Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Antimicrobial Resistance Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antimicrobial Resistance Diagnostics Market

8.1. Asia-Pacific Antimicrobial Resistance Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antimicrobial Resistance Diagnostics Market

9.1. China Antimicrobial Resistance Diagnostics Market Overview

9.2. China Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antimicrobial Resistance Diagnostics Market

10.1. India Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antimicrobial Resistance Diagnostics Market

11.1. Japan Antimicrobial Resistance Diagnostics Market Overview

11.2. Japan Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antimicrobial Resistance Diagnostics Market

12.1. Australia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antimicrobial Resistance Diagnostics Market

13.1. Indonesia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antimicrobial Resistance Diagnostics Market

14.1. South Korea Antimicrobial Resistance Diagnostics Market Overview

14.2. South Korea Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antimicrobial Resistance Diagnostics Market

15.1. Western Europe Antimicrobial Resistance Diagnostics Market Overview

15.2. Western Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antimicrobial Resistance Diagnostics Market

16.1. UK Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antimicrobial Resistance Diagnostics Market

17.1. Germany Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antimicrobial Resistance Diagnostics Market

18.1. France Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antimicrobial Resistance Diagnostics Market

19.1. Italy Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antimicrobial Resistance Diagnostics Market

20.1. Spain Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antimicrobial Resistance Diagnostics Market

21.1. Eastern Europe Antimicrobial Resistance Diagnostics Market Overview

21.2. Eastern Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antimicrobial Resistance Diagnostics Market

22.1. Russia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antimicrobial Resistance Diagnostics Market

23.1. North America Antimicrobial Resistance Diagnostics Market Overview

23.2. North America Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antimicrobial Resistance Diagnostics Market

24.1. USA Antimicrobial Resistance Diagnostics Market Overview

24.2. USA Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antimicrobial Resistance Diagnostics Market

25.1. Canada Antimicrobial Resistance Diagnostics Market Overview

25.2. Canada Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antimicrobial Resistance Diagnostics Market

26.1. South America Antimicrobial Resistance Diagnostics Market Overview

26.2. South America Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antimicrobial Resistance Diagnostics Market

27.1. Brazil Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antimicrobial Resistance Diagnostics Market

28.1. Middle East Antimicrobial Resistance Diagnostics Market Overview

28.2. Middle East Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antimicrobial Resistance Diagnostics Market

29.1. Africa Antimicrobial Resistance Diagnostics Market Overview

29.2. Africa Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antimicrobial Resistance Diagnostics Market Competitive Landscape And Company Profiles

30.1. Antimicrobial Resistance Diagnostics Market Competitive Landscape

30.2. Antimicrobial Resistance Diagnostics Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Antimicrobial Resistance Diagnostics Market Other Major And Innovative Companies

31.1. bioMérieux S.A.

31.2. Sysmex Corporation

31.3. Bio-Rad Laboratories Inc.

31.4. QIAGEN N.V.

31.5. Seegene Inc.

31.6. Alifax S.r.l.

31.7. Accelerate Diagnostics Inc.

31.8. Lumos Diagnostics Holdings Pty Ltd

31.9. Molsid SAS

31.10. Genetic Signatures Limited

31.11. iFAST Diagnostics Ltd

31.12. Astek Diagnostics Inc.

31.13. OpGen Inc.

31.14. T2 Biosystems

31.15. Jiangsu Medomics Medical Technology Co. Ltd.

32. Global Antimicrobial Resistance Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antimicrobial Resistance Diagnostics Market

34. Recent Developments In The Antimicrobial Resistance Diagnostics Market

35. Antimicrobial Resistance Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Antimicrobial Resistance Diagnostics Market In 2029 - Countries Offering Most New Opportunities

35.2 Antimicrobial Resistance Diagnostics Market In 2029 - Segments Offering Most New Opportunities

35.3 Antimicrobial Resistance Diagnostics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Antimicrobial Resistance Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Instruments And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Antimicrobial Resistance Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Antimicrobial Resistance Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: F. Hoffmann-La Roche AG Financial Performance
  • Table 78: Thermo Fisher Scientific Inc. Financial Performance
  • Table 79: Abbott Laboratories Financial Performance
  • Table 80: Danaher Corporation Financial Performance
  • Table 81: Becton Dickinson and Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Antimicrobial Resistance Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Instruments And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Antimicrobial Resistance Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Antimicrobial Resistance Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: F. Hoffmann-La Roche AG Financial Performance
  • Figure 78: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 79: Abbott Laboratories Financial Performance
  • Figure 80: Danaher Corporation Financial Performance
  • Figure 81: Becton Dickinson and Company Financial Performance

Frequently Asked Questions

Antimicrobial resistance (AMR) diagnostics are tests used to detect the presence of microorganisms that have developed resistance to antibiotics or other antimicrobial agents. These diagnostics help identify the specific pathogen and determine which drugs it is resistant or susceptible to, enabling targeted and effective treatment. Antimicrobial resistance (AMR) diagnostics are essential for controlling the spread of resistant infections and guiding appropriate antimicrobial use in both clinical and public health settings. For further insights on the Antimicrobial Resistance Diagnostics market, request a sample here

The Antimicrobial Resistance Diagnostics market major growth driver - Rising Drug-Resistant Infections Driving The Growth Of The Market Due To The Need For Early Detection And Targeted Treatment. For further insights on the Antimicrobial Resistance Diagnostics market, request a sample here

The Antimicrobial Resistance Diagnostics market size has grown strongly in recent years. The antimicrobial resistance diagnostics market size has grown strongly in recent years. It will grow from $4.10 billion in 2024 to $4.41 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing incidence of hospital-acquired infections, rising misuse of antibiotics in humans and animals, growing burden of multidrug-resistant organisms, increasing public health surveillance programs, and rising diagnostic testing in infectious diseases. The antimicrobial resistance diagnostics market size is expected to see strong growth in the next few years. It will grow to $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growing demand for rapid diagnostic tools, increasing awareness of antimicrobial stewardship, rising government funding for resistance tracking, expanding use of point-of-care testing, and increasing need for early infection detection. Major trends in the forecast period include technological advancements in diagnostic platforms, innovation in resistance gene detection methods, rising investment in research and development, development of portable testing devices, and innovation in multiplex and high-throughput testing. For further insights on the Antimicrobial Resistance Diagnostics market, request a sample here

The antimicrobial resistance diagnostics market covered in this report is segmented –
1) By Product Type: Kits And Reagents, Instruments And Consumables
2) By Pathogen: Drug-Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRntS), Other Pathogens
3) By Technology: Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), Mass Spectrometry, Rapid And Point Of Care, Other Technologies
4) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Polymerase Chain Reaction (PCR) Reagents, Immunoassay Reagents, Stains And Dyes, Culture Media
2) By Instruments And Consumables: Polymerase Chain Reaction (PCR) Machines, Ultraviolet-Visible (UV-Vis) Spectrophotometers, Next-Generation Sequencing (NGS) Systems, Microarray Scanners, Automated Liquid Handlers, Sample Collection Tubes And Swabs For further insights on the Antimicrobial Resistance Diagnostics market,
request a sample here

North America was the largest region in the antimicrobial resistance diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Antimicrobial Resistance Diagnostics market, request a sample here.

Major companies operating in the antimicrobial resistance diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMérieux S.A., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Seegene Inc., Alifax S.r.l., Accelerate Diagnostics Inc., Lumos Diagnostics Holdings Pty Ltd, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc., OpGen Inc., T2 Biosystems, Jiangsu Medomics Medical Technology Co. Ltd. . For further insights on the Antimicrobial Resistance Diagnostics market, request a sample here.

Major trends in the Antimicrobial Resistance Diagnostics market include Technological Innovations Of Multiplex PCR Assays To Enhance Diagnostic Speed And Accuracy. For further insights on the Antimicrobial Resistance Diagnostics market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon